Patient presents with clinical findings consistent with healthcare-associated pneumonia (HAP).  Onset of symptoms, including productive cough with purulent sputum, fever, chills, and dyspnea, occurred 48 hours after admission for [initial admitting diagnosis].  Prior to this, the patient was [patient location, e.g., residing at home, in a skilled nursing facility].  Physical examination reveals [relevant physical exam findings, e.g., diminished breath sounds in the right lower lobe, crackles, tachypnea, tachycardia].  Chest X-ray demonstrates [radiographic findings, e.g., infiltrate in the right lower lobe].  Differential diagnosis includes community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, and aspiration pneumonia.  Based on the timing of symptom onset and patient history, HAP is the most likely diagnosis.  Laboratory studies, including complete blood count with differential, blood cultures, and sputum cultures, have been ordered to identify the causative organism and guide antibiotic therapy.  Empiric antibiotic treatment initiated with [antibiotic name and dosage] given [route of administration].  Patient is being closely monitored for clinical response to therapy, including oxygen saturation, respiratory rate, and temperature.  Plan to adjust antibiotic regimen based on culture results and clinical course.  ICD-10 code J18.9 Pneumonia, unspecified organism will be utilized pending culture results, with potential for refinement to a more specific code.  DRG assignment will depend on the patient's overall clinical picture and comorbidities.  This documentation supports medical billing for HAP treatment and facilitates accurate coding for reimbursement.  The patient's prognosis is currently guarded and dependent on response to treatment.